At SLAS 2026, three orchestration platforms launched in the same week, multiple instruments shipped with API-first positioning, and two vendors debuted competing target engagement assays head-to-head. The closed-loop lab is now a procurement fight. On February 5, Ginkgo Bioworks and OpenAI announced that GPT-5 had autonomously designed and iterated a large cell-free protein synthesis campaign…
